Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open study of subcutaneous immunoglobulin versus current best medical care in complex regional pain syndrome
2009-015242-30Phase 4Terminated
- Sponsor
- The Walton Centre
- Start
- Sep 2009
- Countries
- 1
01
Overview
Phase 4, open-label trial of polyvalent human immunoglobulin in complex regional pain syndrome (CRPS) (2 arms), sponsored by The Walton Centre. Primary endpoint: Primary efficacy endpoint. Started Sep 2009; status: terminated.
02
Drugs
polyvalent human immunoglobulin
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on 2009-015242-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015242-30.